http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21015138

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial
endingPage 266
issn 0012-6667
1179-1950
issueIdentifier 2
pageRange 257-266
publicationName Drugs
startingPage 257
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c1b9f1c2d5cc1361ccf28b0108bd7179
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_80ecf2ca15d190344540416076ae8636
bibliographicCitation Mok TS, Cheng Y, Zhou X, Lee KH, Nakagawa K, Niho S, Chawla A, Rosell R, Corral J, Migliorino MR, Pluzanski A, Noonan K, Tang Y, Pastel M, Wilner KD, Wu Y. Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations. Drugs. 2020 Dec 17;81(2):257–66. doi: 10.1007/s40265-020-01441-6.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_414a4dbce3504560f16a6be319929851
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da6d0bfff1c621a15ccc0e1bba2cff15
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1915f73e05fa3df698dab4c3ad332961
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0a7fe354e36a1270ae7e1835f665105
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29503076ba924b7dd2007717c1a512c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e50176436b534390fc7bbb1f818e5c9e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_896ac75f895dc09f2d817aed02dc15d1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e5767020e284c808d84e050a4e37568
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3611-0258
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f446a17071884a86cbea077e63772ffb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8869ce0a826aeb6c4cc539ce23ee6063
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a50979798a038e0956a2952dbec6591d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_051edb1d62f22a9f0ffea8971448db4d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa06df4a91cfb6c7251bd21250836372
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4531517982ebeba35fc6e4502bd06e98
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de5acac04ad4b950cd9db5ea51f319f3
date 2020-12-17^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC7932969
https://doi.org/10.1007/s40265-020-01441-6
https://pubmed.ncbi.nlm.nih.gov/33331989
isPartOf https://portal.issn.org/resource/ISSN/0012-6667
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453
https://portal.issn.org/resource/ISSN/1179-1950
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations
discusses http://id.nlm.nih.gov/mesh/M0490629
http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0581236
http://id.nlm.nih.gov/mesh/M0500817
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0444984
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000494
http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D000077156Q000494
http://id.nlm.nih.gov/mesh/D052999Q000494
http://id.nlm.nih.gov/mesh/D047428Q000494
http://id.nlm.nih.gov/mesh/D008175Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D052999Q000008
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D066246Q000378
http://id.nlm.nih.gov/mesh/D009154
http://id.nlm.nih.gov/mesh/D000077156Q000008
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D066246Q000235
http://id.nlm.nih.gov/mesh/D008175Q000378
http://id.nlm.nih.gov/mesh/D008175Q000175
http://id.nlm.nih.gov/mesh/D066246Q000037
http://id.nlm.nih.gov/mesh/D047428Q000008
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D002289Q000175
http://id.nlm.nih.gov/mesh/D002289Q000378
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11511120
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8808
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10030
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7429
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168

Showing number of triples: 1 to 80 of 80.